[1]杨增烨,张芙蓉,高喜斌.血清内毒素水平对脑血管患者经择期介入手术治疗后支架内再狭窄的预测研究[J].陕西医学杂志,2022,51(1):29-32.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.007]
　YANG Zengye,ZHANG Furong,GAO Xibin.Predictive value of serum endotoxin level on in stent restenosis in patients with cerebrovascular disease after elective interventional therapy[J].,2022,51(1):29-32.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.007]
点击复制

血清内毒素水平对脑血管患者经择期介入手术治疗后支架内再狭窄的预测研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年1期
页码:
29-32
栏目:
临床研究
出版日期:
2022-01-05

文章信息/Info

Title:
Predictive value of serum endotoxin level on in stent restenosis in patients with cerebrovascular disease after elective interventional therapy
作者:
杨增烨; 张芙蓉; 高喜斌
(延安大学附属医院神经内科,陕西 延安 716000)
Author(s):
YANG Zengye; ZHANG Furong; GAO Xibin
(Department of Neurology,Affiliated Hospital of Yan'an University,Yan'an 716000,China)
关键词:
脑血管疾病;  介入手术;  再狭窄;  内毒素;  相关性;  预测价值
Keywords:
Cerebrovascular disease;  Interventional surgery;  Restenosis;  Endotoxin;  Correlation;  Predictive value
分类号:
R 743
DOI:
DOI:10.3969/j.issn.1000-7377.2022.01.007
文献标志码:
A
摘要:
目的:探讨与分析血清内毒素水平对脑血管患者经择期介入手术治疗后支架内再狭窄的预测价值。方法:选择脑血管疾病患者110例作为研究对象,所有患者都给予择期介入手术治疗,检测术前1 d血清内毒素水平,随访调查患者再狭窄发生情况并进行预测价值分析。结果:在110例患者中,术后1年发生再狭窄21例(狭窄组),发生率为19.1%,其中轻度17例,中度3例,重度1例。两组术前1 d的空腹血糖、血脂水平对比差异无统计学意义(均P>0.05),狭窄组的血清内毒素水平高于非狭窄组(P<0.05)。两组术后14 d的颈动脉狭窄率都低于术前1 d(P<0.05),手术前后组内与组间对比差异都无统计学意义(均P>0.05)。在110例患者中,Spearsman分析显示术后再狭窄与内毒素存在相关性(r=0.672,P=0.000)。Logistic回归分析显示内毒素(OR=5.305,P=0.011)为导致术后再狭窄发生的主要影响因素(P<0.05)。受试者工作特征曲线(ROC)分析显示内毒素对脑血管介入术后再狭窄的预测曲线下面积为0.789。结论:脑血管介入术后再狭窄比较常见,术前血清内毒素水平对于预测术后再狭窄的发生具有重要价值。
Abstract:
Objective:To explore and analyze the predictive value of serum endotoxin level on in stent restenosis in patients with cerebrovascular disease after elective interventional therapy.Methods:110 cases of patients with cerebrovascular disease were selected as the research objects.All patients were treated with elective interventional surgery.The serum endotoxin level was detected one day before surgery,and patients were followed up to investigate restenosis,and predictive value analysis was performed.Results:Among 110 patients,restenosis occurred in 21 cases(stenosis group)one year after operation,with an incidence of 19.1%,including 17 cases of mild,3 cases of moderate and 1 case of severe.There was no significant difference in fasting blood glucose and blood lipid levels between the two groups one day before operation(all P>0.05).The level of serum endotoxin in stenosis group was higher than that in non stenosis group(P<0.05).The carotid stenosis rate of the two groups at 14 days after operation were lower than that at 1 day before operation(all P<0.05).There was no significant difference between the two groups before and after operation(all P<0.05).Spearman analysis showed that there was a correlation between postoperative restenosis and endotoxin in 110 patients(r=0.672,P=0.000).Logistic regression analysis showed that endotoxin was the main factor leading to postoperative restenosis(OR=5.305,P=0.011).Receiver operating characteristic(ROC)curve analysis showed that the area under the curve of endotoxin predicting restenosis after cerebrovascular intervention was 0.789.Conclusion:Restenosis after cerebrovascular intervention is common.Preoperative serum endotoxin level is of great value in predicting the occurrence of postoperative restenosis.

参考文献/References:

[1] 龙晓东,李爱国,刘之彝,等.早期介入栓塞治疗脑动脉瘤破裂疗效及安全性研究[J].陕西医学杂志,2019,48(8):1000-1002.
[2] 陈俊臣,任晓乐,李 倩,等.解痉汤治疗动脉瘤性蛛网膜下腔出血后脑血管痉挛临床研究[J].陕西中医,2020,41(8):1055-1058.
[3] 李春伟,王朝刚,伊志强,等.脑血管串联狭窄血管内治疗的临床效果[J].中华外科杂志,2021,59(3):203-209.
[4] 夏金超,汪勇锋,张 坤,等.有症状的慢性颈内动脉闭塞患者开通术的临床初步疗效[J].中华放射学杂志,2021,55(5):490-494.
[5] 许 斌,白卫星,王子亮,等.药物涂层球囊治疗脑血管支架成形术后反复再狭窄一例[J].中华放射学杂志,2020,54(1):75-76.
[6] 夏金超,汪勇锋,许岗勤,等.不同类型支架治疗椎动脉开口狭窄的对照研究[J].介入放射学杂志,2020,29(2):136-139.
[7] Stevens JR,Zamani A,Osborne JIA,et al.Critical evaluation of stents in coronary angioplasty:Asystematic review[J].J Clin Hypertens(Greenwich),2021,20(1):46-51.
[8] Wu X,Li L,He L.Drug-Coated balloon versus drug-eluting stent in patients with small-vessel coronary artery disease:A meta-analysis of randomized controlled trials[J].Cardiol Res Pract,2021,8(12):7635-7639.
[9] Yang X,Yang Y,Guo J,et al.Targeting the epigenome in in-stent restenosis:From mechanisms to therapy[J].Mol Ther Nucleic Acids,2021,23(7):1136-1160.
[10] 周志龙,朱良付,李天晓,等.症状性椎动脉颅内段非急性闭塞血管内开通治疗研究[J].中国脑血管病杂志,2020,17(7):391-397.
[11] 邵秋季,李 强,李天晓,等.三维T1加权可变反转角快速自旋回波序列管壁成像技术在颅内动脉狭窄支架术后随访中的应用[J].介入放射学杂志,2020,29(8):753-757.
[12] 陈 飞,杨秀春,鲁静朝,等.药物涂层球囊与药物洗脱支架治疗冠状动脉支架内再狭窄疗效分析[J].河北医药,2020,42(7):1051-1053,1057.
[13] 杨文进,张 磊,李子付,等.大脑中动脉粥样硬化性狭窄伴急性闭塞血管成形疗效分析[J].第二军医大学学报,2020,41(2):122-128.
[14] Evans CE,Iruela-Arispe ML,Zhao YY.Mechanisms of endothelial regeneration and vascular repair and their application to regenerative medicine[J].Am J Pathol,2021,191(1):52-65.
[15] 姜海波,王小姗,曹 辉,等.支架置入术治疗椎动脉起始段狭窄的临床疗效及术后支架内再狭窄的影响因素分析[J].现代生物医学进展,2020,20(22):4274-4278.
[16] 潘香君,惠品晶,颜燕红,等.颈动脉内膜切除术治疗缺血性卒中的疗效及其与粥样斑块特征的关系[J].中华神经外科杂志,2020,36(11):1151-1155.
[17] Hu H,Shen L.Drug-coated balloons in the treatment of acute myocardial infarction(Review)[J].Biomedicines,2021,21(5):464-468.
[18] Marsman MS,Wetterslev J,Jahrome AK,et al.Carotid endarterectomy with patch angioplasty versus primary closure in patients with symptomatic and significant stenosis:A systematic review with meta-analyses and trial sequential analysis of randomized clinical trials[J].Syst Rev,2021,10(1):139-143.
[19] 潘香君,惠品晶,丁亚芳,等.颈动脉内膜切除术治疗症状性颈动脉狭窄的疗效及其与手术时机的关系[J].中华神经外科杂志,2020,36(1):32-37.
[20] Nesti L,Tricò D,Mengozzi A,et al.Rethinking pioglitazone as a cardioprotective agent:A new perspective on an overlooked drug[J].Cardiovasc Diabetol,2021,20(1):109-114.
[21] Normahani P,Khan B,Sounderajah V,et al.Applications of intraoperative duplex ultrasound in vascular surgery:A systematic review[J].Ultrasound J,2021,13(1):8-11.
[22] 韩芸峰,杨 军,王 涛.显微颈动脉内膜切除术治疗放疗后颈动脉狭窄[J].中国微创外科杂志,2020,20(7):619-623.
[23] 田鸿福,张克忠.弓上颅外动脉支架置入术后再狭窄危险因素研究[J].中国临床神经科学,2020,28(3):273-280.
[24] Azzi N,Shatila W.Update on coronary artery bioresorbable vascular scaffolds in percutaneous coronary revascularization[J].Rev Cardiovasc Med,2021,22(1):137-145.
[25] Cecchini AL,Gasbarrini A,Massetti M,et al.Ethnic difference of thrombogenicity in patients with cardiovascular disease:A pandora box to explain prognostic differences[J].Int J Mol Sci,2021,51(3):202-221.

备注/Memo

备注/Memo:
基金项目:陕西省教育厅专项科研计划项目(19JK0972)
更新日期/Last Update: 2022-01-09